These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

629 related items for PubMed ID: 33879085

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX, Gan YH, Ge NL, Chen Y, Ma H, Wang Y, Zhang BH, Wang YH, Ye SL, Luo JF, Ren ZG.
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the Efficacy Among Transcatheter Arterial Chemoembolization (TACE)-Radiofrequency Ablation Plus Apatinib, TACE Plus Apatinib, and TACE Alone for Hepatocellular Carcinoma: A Retrospective Study.
    Ouyang T, Cao Y, Chen L, Zheng C.
    Cardiovasc Intervent Radiol; 2022 Jun; 45(6):780-790. PubMed ID: 35410405
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chemoembolization combined radiofrequency ablation vs. chemoembolization alone for treatment of beyond the Milan criteria viable hepatocellular carcinoma (CERFA): study protocol for a randomized controlled trial.
    Lee SK, Yang H, Kwon JH, Shim DJ, Kim D, Nam SW, Yoo SH, Bae SH, Lee A, Lee YJ, Jeon C, Jang JW, Sung PS, Chun HJ, Kim SH, Choi JI, Oh JS, Yang YJ.
    Trials; 2023 Mar 28; 24(1):234. PubMed ID: 36978150
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.
    Ni JY, Liu SS, Xu LF, Sun HL, Chen YT.
    World J Gastroenterol; 2013 Jun 28; 19(24):3872-82. PubMed ID: 23840128
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of transarterial chemoembolization compared with radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma after radiofrequency ablation.
    Wang X, Liang H, Lu Z.
    Minim Invasive Ther Allied Technol; 2020 Dec 28; 29(6):344-352. PubMed ID: 31375044
    [Abstract] [Full Text] [Related]

  • 16. Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma.
    Hirooka M, Hiraoka A, Ochi H, Kisaka Y, Joko K, Michitaka K, Hiasa Y.
    AJR Am J Roentgenol; 2018 Apr 28; 210(4):891-898. PubMed ID: 29412017
    [Abstract] [Full Text] [Related]

  • 17. Comparison of Transarterial Chemoembolization Combined with Radiofrequency Ablation Therapy versus Surgical Resection for Early Hepatocellular Carcinoma.
    Yi PS, Huang M, Zhang M, Xu L, Xu MQ.
    Am Surg; 2018 Feb 01; 84(2):282-288. PubMed ID: 29580359
    [Abstract] [Full Text] [Related]

  • 18. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
    Song MJ, Bae SH, Lee JS, Lee SW, Song DS, You CR, Choi JY, Yoon SK.
    Korean J Intern Med; 2016 Mar 01; 31(2):242-52. PubMed ID: 26874512
    [Abstract] [Full Text] [Related]

  • 19. Drug-Eluting Bead Transarterial Chemoembolization Versus Radiofrequency Ablation as an Initial Treatment of Single Small (≤ 3 cm) Hepatocellular Carcinoma.
    Lee S, Jeong YY, Lee BC, Shin SS, Heo SH, Kim HO, Park C, Jeong WG.
    J Korean Med Sci; 2023 Oct 30; 38(42):e362. PubMed ID: 37904659
    [Abstract] [Full Text] [Related]

  • 20. The effectiveness of radiofrequency ablation for patients with BCLC B1 stage hepatocellular carcinoma downgraded by transarterial chemoembolization.
    Li L, Xin Y, Zhang X, Chen Y, Yang Y, Zhou X, Ye F.
    Clin Res Hepatol Gastroenterol; 2022 Apr 30; 46(4):101878. PubMed ID: 35151909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.